A phase 2 study of idelalisib monotherapy in previously untreated patients ≥ 65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) Meeting Abstract


Authors: Zelenetz, A.; Lamanna, N.; Kipps, T.; Coutre, S.; O'Brien, S.; Graves, J.; Ye, W.; Dubowy, R.; Flinn, I.
Abstract Title: A phase 2 study of idelalisib monotherapy in previously untreated patients ≥ 65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
Meeting Title: 36th World Congress of the International Society of Hematology (ISH)
Journal Title: British Journal of Haematology
Volume: 173
Issue: Suppl.
Meeting Dates: 2016 Apr 18-21
Meeting Location: Glasglow, UK
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2016-04-01
Start Page: 97
Language: English
ACCESSION: WOS:000374543900233
PROVIDER: wos
PUBMED: 27073127
DOI: 10.1111/bjh.14019
Notes: Meeting Abstract: 233 -- 36th World Congress of the International-Society-of-Hematology -- APR 18-21, 2016 -- British Soc Haematol, Glasgow, SCOTLAND -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz
Related MSK Work